CD133 mRNA expression was increased in 62.5% (10/16) of POSTN-positive HCC tissues and was significantly higher than that in 12.5% (1/8) of POSTN-negative HCC tissues (Fig. S1B-C). The gene discussed is POSTN; the disease is hepatocellular carcinoma.